Physiologically-constrained multiagent pharmacokinetic modeling in pancreas using sequential injections of gadoteridol and ferumoxytol reveals differences between healthy pancreas in high-risk patients and both IPMN and pancreatic ductal adenocarcinoma.
This abstract and the presentation materials are available to members only; a login is required.